Search global stocks & ETFs...Ctrl K

Learn Mode

KVUE - Kenvue Inc

95

$17.19

At market close

$17.14

-$0.05 (-0.320%)

Pre Market 5/15/26, 9:17 AM

Score

3.55/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

KVUE

Valuation Score

View as %

Stock Unlock

YTD

Max

Stock Profile

Market Cap

$33.00B

Industry

Consumer products

EPS (TTM)

$0.84

P/E (TTM)

20.35

Div & Yield

$0.83 (4.83%)

FCF Payout Ratio

87.42%

P/S (TTM)

2.16

P/B

3.11

Diluted Shares

1.92B

Ex-Dividend

2026-05-13

Next Earnings

08-07 (Est)

Forward P/E

14.45

Payout Ratio

98.25%

P/FCF (TTM)

18.10

FCF Yield

5.52%

Earnings Yield

4.91%

52 Week Range

Score Card

Explore Scores Tab

3.55

Good

Kenvue Inc has seen its revenue decline by -0.07% over the past year, which means the company is losing sales/customers. However, it has seen its net income increase by 53.6% over the past year, which suggests its profits are growing at a strong rate.

Valuation Model

Key Score

5.00

Very Good

Management

5.00

Very Good

Growth

1.00

Very Bad

Profitability

1.00

Very Bad

Fin. Health

2.00

Bad

Dividends

1.00

Very Bad

Analyst

3.00

Average

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

2 new filings were in the last 7 days

Filter Form Types

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-12 16:27:27

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-05-08 16:12:52

Form 10-Q

General form for quarterly financial reports under Section 13 or 15(d)

Filed on 2026-05-07 07:50:52

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-05-07 06:32:39

Form SCHEDULE 13G

Unknown Form Type

Filed on 2026-05-06 11:23:36

Form SCHEDULE 13G

Unknown Form Type

Filed on 2026-04-30 11:04:34

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-04-15 09:06:38

Form ARS

Unknown Form Type

Filed on 2026-04-08 16:22:00

Form DEFA14A

Additional definitive proxy soliciting materials

Filed on 2026-04-08 16:21:01

Form DEF 14A

Also known as a 'definitive proxy statement', is a required filing when a shareholder vote is required

Filed on 2026-04-08 16:19:16

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-01 17:00:16

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-31 16:29:51

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-04-25

High:

$25.32

47.3%

Avg:

$20.17

17.4%

Low:

$18.18

5.8%

(% change is relative to the current stock price: $17.19)

Analyst Recommendations

Go to Analyst Tab

2.75

Average

Strong Buy (0)

Buy (1)

75%

Hold (15)

10%

Sell (2)

10%

Strong Sell (2)

About

Website
https://www.kenvue.com
Address
1 Kenvue Way, Summit NEW JERSEY, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=1944048

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. The company is headquartered in Summit, New Jersey and currently employs 21,780 full-time employees. The company went IPO on 2023-05-04. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).

IPO Date

2023-05-04

Industry

Consumer products

Total Employees

21,890

Exchange

New York Stock Exchange, Inc.

Reporting Currency

USD

GICS

Personal Care Products

GICS Sub

Personal Care Products

GICS Sector

Consumer Staples

GICS Group

Household & Personal Products

KVUE - Kenvue Inc

95

$17.19

$17.14

-$0.05 (-0.320%)

3.55/5

Stock Unlock

Stock Profile

Score Card

Good

Insider Transactions

Market News

Form 4

Filed on 2026-05-12 16:27:27

Form 144

Filed on 2026-05-08 16:12:52

Form 10-Q

Filed on 2026-05-07 07:50:52

Form 8-K

Filed on 2026-05-07 06:32:39

Form SCHEDULE 13G

Filed on 2026-05-06 11:23:36

Form SCHEDULE 13G

Filed on 2026-04-30 11:04:34

Form 8-K

Filed on 2026-04-15 09:06:38

Form ARS

Filed on 2026-04-08 16:22:00

Form DEFA14A

Filed on 2026-04-08 16:21:01

Form DEF 14A

Filed on 2026-04-08 16:19:16

Form 4

Filed on 2026-04-01 17:00:16

Form 4

Filed on 2026-03-31 16:29:51

Financials

Price Targets

47.3%

17.4%

5.8%

Analyst Recommendations

About

Similar Stocks